Evidence map›Paper›PMID 34883774›Full record

ArticlePolymers2021

Evaluation of the Biocompatibility and Endothelial Differentiation Capacity of Mesenchymal Stem Cells by Polyethylene Glycol Nanogold Composites.

Huey-Shan Hung, Yi-Chin Yang, Wei-Chien Kao, Chun-An Yeh, Kai-Bo Chang, Cheng-Ming Tang, Hsien-Hsu Hsieh, Hsu-Tung Lee

Open access · goldAbstract read
In one paragraph

Article in Polymers, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Huey-Shan HungGraduate Institute of Biomedical Science, China Medical University, Taichung 40402, Taiwan.ORCID 0000-0003-4161-2428
Yi-Chin YangDepartment of Neurosurgery, Neurological Institute, Taichung Veterans General Hospital, Taichung 407204, Taiwan.ORCID 0000-0002-9651-3761
Wei-Chien KaoGraduate Institute of Biomedical Science, China Medical University, Taichung 40402, Taiwan.
Chun-An YehGraduate Institute of Biomedical Science, China Medical University, Taichung 40402, Taiwan.
Kai-Bo ChangGraduate Institute of Biomedical Science, China Medical University, Taichung 40402, Taiwan.
Cheng-Ming TangCollege of Oral Medicine, Chung Shan Medical University, Taichung 40201, Taiwan.ORCID 0000-0003-2103-6670
Hsien-Hsu HsiehBlood Bank, Taichung Veterans General Hospital, Taichung 407204, Taiwan.ORCID 0000-0003-4985-7446
Hsu-Tung LeeCancer Prevention and Control Center, Taichung Veterans General Hospital, Taichung 407204, Taiwan.
China Medical University · TWTaichung Veterans General Hospital · TWChung Shan Medical University · TWNational Chung Hsing University · TW

Funding

Taichung Veterans General Hospital TCVGH-CTUST1107701
6 · The paper itself

Abstract

Cardiovascular Diseases (CVDs) such as atherosclerosis, where inflammation occurs in the blood vessel wall, are one of the major causes of death worldwide. Mesenchymal Stem Cells (MSCs)-based treatment coupled with nanoparticles is considered to be a potential and promising therapeutic strategy for vascular regeneration. Thus, angiogenesis enhanced by nanoparticles is of critical concern. In this study, Polyethylene Glycol (PEG) incorporated with 43.5 ppm of gold (Au) nanoparticles was prepared for the evaluation of biological effects through in vitro and in vivo assessments. The physicochemical properties of PEG and PEG-Au nanocomposites were first characterized by UV-Vis spectrophotometry (UV-Vis), Fourier-transform infrared spectroscopy (FTIR), and Atomic Force Microscopy (AFMs). Furthermore, the reactive oxygen species scavenger ability as well as the hydrophilic property of the nanocomposites were also investigated. Afterwards, the biocompatibility and biological functions of the PEG-Au nanocomposites were evaluated through in vitro assays. The thin coating of PEG containing 43.5 ppm of Au nanoparticles induced the least platelet and monocyte activation. Additionally, the cell behavior of MSCs on PEG-Au 43.5 ppm coating demonstrated better cell proliferation, low ROS generation, and enhancement of cell migration, as well as protein expression of the endothelialization marker CD31, which is associated with angiogenesis capacity. Furthermore, anti-inflammatory and endothelial differentiation ability were both evaluated through in vivo assessments. The evidence demonstrated that PEG-Au 43.5 ppm implantation inhibited capsule formation and facilitated the expression of CD31 in rat models. TUNEL assay also indicated that PEG-Au nanocomposites would not induce significant cell apoptosis. The above results elucidate that the surface modification of PEG-Au nanomaterials may enable them to serve as efficient tools for vascular regeneration grafts.

Indexed as

endothelializationgold nanoparticlesmesenchymal stem cellspolyethylene glycolvascular regeneration

Identifiers

PMID34883774
PMCPMC8659436
OpenAlexW4200502350

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.